Epidemiology of esophageal cancer

World Journal of Gastroenterology

Volumn 19, Issue 34, 2013, Pages 5598-5606

  Zhang, Yuwei ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Barrett's esophagus; Cyclin D1 G870A; Esophageal neoplasm; Polymorphism; Risk factor; Susceptibility

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; ALPHA TOCOPHEROL; ASCORBIC ACID; CAROTENE; CYCLIN D1; EFLORNITHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; RETINOID; SELENIUM;

ANATOMY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; DNA POLYMORPHISM; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; GASTROESOPHAGEAL REFLUX; GENETIC VARIABILITY; HUMAN; INCIDENCE; INFLAMMATION; OBESITY; PATHOLOGY; PHOTODYNAMIC THERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SMOKING; SURVIVAL RATE;

BARRETT'S ESOPHAGUS; CYCLIN D1 G870A; ESOPHAGEAL NEOPLASM; POLYMORPHISM; RISK FACTOR; SUSCEPTIBILITY;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HUMANS; INCIDENCE; MASS SCREENING; RISK FACTORS;

EID: 84883851981     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i34.5598     Document Type: Review

References (87)

1. Retraction: The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma. J Exp Clin Cancer Res 2011; 30: 19 [PMID: 21324197 DOI: 10.1186/1756-9966-30-19]
2. Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol 2008; 5: 517-526 [PMID: 18679388 DOI: 10.1038/ncpgasthep1223]
3. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesopha-geal carcinoma. Lancet 2013; 381: 400-412 [PMID: 23374478 DOI: 10.1016/S0140-6736(12)60643-6]
4. Mao WM, Zheng WH, Ling ZQ. Epidemiologic risk factors for esophageal cancer development. Asian Pac J Cancer Prev 2011; 12: 2461-2466 [PMID: 22320939]
5. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241-2252 [PMID: 14657432 DOI: 10.1056/NEJM-ra035010]
6. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, Fraumeni JF. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003; 95: 1404-1413 [PMID: 13130116]
7. Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol 1999; 26: 2-8 [PMID: 10566604]
8. Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol 2008; 103: 2694-2699 [PMID: 18853967 DOI: 10.1111/j.1572-0241.2008.02191.x]
9. Blot WJ, Devesa SS, Fraumeni JF. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA 1993; 270: 1320 [PMID: 8360967]
10. Young JL, Percy CL, Asire AJ, Berg JW, Cusano MM, Gloeck-ler LA, Horm JW, Lourie WI, Pollack ES, Shambaugh EM. Cancer incidence and mortality in the United States, 1973-77. Natl Cancer Inst Monogr 1981; (57): 1-187 [PMID: 7278952]
11. Kwatra KS, Prabhakar BR, Jain S, Grewal JS. Sarcomatoid carcinoma (carcinosarcoma) of the esophagus with extensive areas of osseous differentiation: a case report. Indian J Pathol Microbiol 2003; 46: 49-51 [PMID: 15027719]
12. Cook MB. Non-acid reflux: the missing link between gastric atrophy and esophageal squamous cell carcinoma? Am J Gastroenterol 2011; 106: 1930-1932 [PMID: 22056574 DOI: 10.1038/ajg.2011.288]
13. Dawsey SM, Lewin KJ, Wang GQ, Liu FS, Nieberg RK, Yu Y, Li JY, Blot WJ, Li B, Taylor PR. Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China. Cancer 1994; 74: 1686-1692 [PMID: 8082069]
14. Dawsey SM, Lewin KJ, Liu FS, Wang GQ, Shen Q. Esophageal morphology from Linxian, China. Squamous histologic fndings in 754 patients. Cancer 1994; 73: 2027-2037 [PMID: 8156507]
15. Huang Q, Fang DC, Yu CG, Zhang J, Chen MH. Barrett' s esophagus-related diseases remain uncommon in China. J Dig Dis 2011; 12: 420-427 [PMID: 22118690 DOI: 10.1111/ j.1751-2980.2011.00535.x]
16. Kountourakis P, Papademetriou K, Ardavanis A, Papami-chael D. Barrett's esophagus: treatment or observation of a major precursor factor of esophageal cancer? J BUON 2011; 16: 425-430 [PMID: 22006743]
17. Conteduca V, Sansonno D, Ingravallo G, Marangi S, Russi S, Lauletta G, Dammacco F. Barrett's esophagus and esopha-geal cancer: an overview. Int J Oncol 2012; 41: 414-424 [PMID: 22615011 DOI: 10.3892/ijo.2012.1481]
18. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 2009; 24: 729-735 [PMID: 19646015 DOI: 10.1111/j.1440-1746.2009.05824.x]
19. Shaheen N, Ransohoff DF. Gastroesophageal refux, barrett esophagus, and esophageal cancer: scientifc review. JAMA 2002; 287: 1972-1981 [PMID: 11960540]
20. Pedrazzani C, Bernini M, Giacopuzzi S, Pugliese R, Catalano F, Festini M, Rodella L, de Manzoni G. Evaluation of Siewert classifcation in gastro-esophageal junction adenocarcinoma: What is the role of endoscopic ultrasonography? J Surg Oncol 2005; 91: 226-231 [PMID: 16121346 DOI: 10.1002/jso.20302]
21. Suh YS, Han DS, Kong SH, Lee HJ, Kim YT, Kim WH, Lee KU, Yang HK. Should adenocarcinoma of the esophagogas-tric junction be classifed as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification. Ann Surg 2012; 255: 908-915 [PMID: 22504190 DOI: 10.1097/SLA.0b013e31824beb95]
22. Schumacher G, Schmidt SC, Schlechtweg N, Roesch T, Sac-chi M, von Dossow V, Chopra SS, Pratschke J, Zhukova J, Stieler J, Thuss-Patience P, Neuhaus P. Surgical results of patients after esophageal resection or extended gas-trectomy for cancer of the esophagogastric junction. Dis Esophagus 2009; 22: 422-426 [PMID: 19191862 DOI: 10.1111/ j.1442-2050.2008.00923.x]
23. Hasegawa S, Yoshikawa T, Aoyama T, Hayashi T, Yamada T, Tsuchida K, Cho H, Oshima T, Yukawa N, Rino Y, Masuda M, Tsuburaya A. Esophagus or stomach? The seventh TNM classifcation for Siewert type II/III junctional adenocarcino-ma. Ann Surg Oncol 2013; 20: 773-779 [PMID: 23224137 DOI: 10.1245/s10434-012-2780-x]
24. Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol 2012; 19: 677-683 [PMID: 21822549 DOI: 10.1245/s10434-011-1983-x]
25. Fang WL, Wu CW, Chen JH, Lo SS, Hsieh MC, Shen KH, Hsu WH, Li AF, Lui WY. Esophagogastric junction adeno-carcinoma according to Siewert classification in Taiwan. Ann Surg Oncol 2009; 16: 3237-3244 [PMID: 19636628 DOI: 10.1245/s10434-009-0636-9]
26. Yoon HY, Kim HI, Kim CB. [Clinicopathologic characteristics of adenocarcinoma in cardia according to Siewert classification]. Korean J Gastroenterol 2008; 52: 293-297 [PMID: 19077475]
27. Szántó I, Vörös A, Gonda G, Nagy P, Altorjay A, Banai J, Gamal EM, Cserepes E. [Siewert-Stein classification of ad-enocarcinoma of the esophagogastric junction]. Magy Seb 2001; 54: 144-149 [PMID: 11432164]
28. Ku GY, Ilson DH. Adjuvant therapy in esophagogastric adenocarcinoma: controversies and consensus. Gastrointest Cancer Res 2012; 5: 85-92 [PMID: 22888388]
29. Fein R, Kelsen DP, Geller N, Bains M, McCormack P, Brennan MF. Adenocarcinoma of the esophagus and gastroesophageal junction. Prognostic factors and results of therapy. Cancer 1985; 56: 2512-2518 [PMID: 4042074]
30. Patel AN, Preskitt JT, Kuhn JA, Hebeler RF, Wood RE, Ur-schel HC. Surgical management of esophageal carcinoma. Proc (Bayl Univ Med Cent) 2003; 16: 280-284 [PMID: 16278698]
31. McCollum AD, Wu B, Clark JW, Kulke MH, Enzinger PC, Ryan DP, Earle CC, Michelini A, Fuchs CS. The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer. Am J Clin Oncol 2006; 29: 40-44 [PMID: 16462501 DOI: 10.1097/01. coc.0000190456.83788.51]
32. Jiao X, Krasna MJ. Clinical signifcance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. Ann Thorac Surg 2002; 74: 278-284 [PMID: 12118789]
33. Erasmus JJ, Munden RF. The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response. Semin Radiat Oncol 2007; 17: 29-37 [PMID: 17185195 DOI: 10.1016/j.semradonc.2006.09.005]
34. Lordick F, Ebert M, Stein HJ. Current treatment approach to locally advanced esophageal cancer: is resection mandatory? Future Oncol 2006; 2: 717-721 [PMID: 17155898 DOI: 10.2217/ 14796694.2.6.717]
35. Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365: 1375-1383 [PMID: 21995385 DOI: 10.1056/NEJMoa1103042]
36. Cummings LC, Cooper GS. Descriptive epidemiology of esophageal carcinoma in the Ohio Cancer Registry. Cancer Detect Prev 2008; 32: 87-92 [PMID: 18406068 DOI: 10.1016/ j.cdp.2008.02.005]
37. Ilson DH. Esophageal cancer chemotherapy: recent advances. Gastrointest Cancer Res 2008; 2: 85-92 [PMID: 19259300]
38. Rasool S, A Ganai B, Syed Sameer A, Masood A. Esophageal cancer: associated factors with special reference to the Kashmir Valley. Tumori 2012; 98: 191-203 [PMID: 22677984 DOI: 10.1700/1088.11929]
39. Khuroo MS, Zargar SA, Mahajan R, Banday MA. High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 1992; 33: 11-15 [PMID: 1740265]
40. Li JY. Epidemiology of esophageal cancer in China. Natl Cancer Inst Monogr 1982; 62: 113-120 [PMID: 7167171]
41. Baquet CR, Commiskey P, Mack K, Meltzer S, Mishra SI. Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 2005; 97: 1471-1478 [PMID: 16334494]
42. Faivre J, Trama A, De Angelis R, Elferink M, Siesling S, Audisio R, Bosset JF, Cervantes A, Lepage C. Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002. Eur J Cancer 2012; 48: 1417-1424 [PMID: 22169462 DOI: 10.1016/ j.ejca.2011.10.038]
43. Cesas A, Bagajevas A. [Combined treatment of esophageal cancer: a review]. Medicina (Kaunas) 2004; 40 Suppl 1: 161-165 [PMID: 15079129]
44. Lepage C, Drouillard A, Jouve JL, Faivre J. Epidemiology and risk factors for oesophageal adenocarcinoma. Dig Liver Dis 2013; 45: 625-629 [PMID: 23453359 DOI: 10.1016/ j.dld.2012.12.020]
45. Blot WJ. Invited commentary: more evidence of increased risks of cancer among alcohol drinkers. Am J Epidemiol 1999; 150: 1138-140; discussion 1141 [PMID: 10588074]
46. D'Onofrio V, Bovero E, Iaquinto G. Characterization of acid and alkaline reflux in patients with Barrett's esophagus. G.O.S.P.E. Operative Group for the study of Esophageal Precancer. Dis Esophagus 1997; 10: 16-22; discussion 22-3 [PMID: 9079268]
47. Guanrei Y, Songliang Q. Endoscopic surveys in high-risk and low-risk populations for esophageal cancer in China with special reference to precursors of esophageal cancer. Endoscopy 1987; 19: 91-95 [PMID: 3608927 DOI: 10.1055/ s-2007-1018250]
48. Oze I, Matsuo K, Wakai K, Nagata C, Mizoue T, Tanaka K, Tsuji I, Sasazuki S, Inoue M, Tsugane S. Alcohol drinking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2011; 41: 677-692 [PMID: 21430021 DOI: 10.1093/jjco/hyr026]
49. Lin J, Zeng R, Cao W, Luo R, Chen J, Lin Y. Hot beverage and food intake and esophageal cancer in southern China. Asian Pac J Cancer Prev 2011; 12: 2189-2192 [PMID: 22296354]
50. Lagergren J, Lagergren P. Recent developments in esopha-geal adenocarcinoma. CA Cancer J Clin 2013; Epub ahead of print [PMID: 23584949 DOI: 10.1002/caac.21185]
51. Nieman KM, Romero IL, Van Houten B, Lengyel E. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta 2013; Epub ahead of print [PMID: 23500888 DOI: 10.1016/j.bbalip.2013.02.010]
52. Duggan C, Onstad L, Hardikar S, Blount PL, Reid BJ, Vaughan TL. Association Between Markers of Obesity and Progression From Barrett's Esophagus to Esophageal Adeno-carcinoma. Clin Gastroenterol Hepatol 2013; 11: 934-943 [PMID: 23466711 DOI: 10.1016/j.cgh.2013.02.017]
53. Carr JS, Zafar SF, Saba N, Khuri FR, El-Rayes BF. Risk factors for rising incidence of esophageal and gastric cardia ad-enocarcinoma. J Gastrointest Cancer 2013; 44: 143-151 [PMID: 23435833 DOI: 10.1007/s12029-013-9480-z]
54. Löfdahl HE, Lu Y, Lagergren P, Lagergren J. Risk factors for esophageal adenocarcinoma after antireflux surgery. Ann Surg 2013; 257: 579-582 [PMID: 23426349 DOI: 10.1097/ SLA.0b013e3182888384]
55. Wu C, Kraft P, Zhai K, Chang J, Wang Z, Li Y, Hu Z, He Z, Jia W, Abnet CC, Liang L, Hu N, Miao X, Zhou Y, Liu Z, Zhan Q, Liu Y, Qiao Y, Zhou Y, Jin G, Guo C, Lu C, Yang H, Fu J, Yu D, Freedman ND, Ding T, Tan W, Goldstein AM, Wu T, Shen H, Ke Y, Zeng Y, Chanock SJ, Taylor PR, Lin D. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet 2012; 44: 1090-1097 [PMID: 22960999 DOI: 10.1038/ng.2411]
56. Wu C, Hu Z, He Z, Jia W, Wang F, Zhou Y, Liu Z, Zhan Q, Liu Y, Yu D, Zhai K, Chang J, Qiao Y, Jin G, Liu Z, Shen Y, Guo C, Fu J, Miao X, Tan W, Shen H, Ke Y, Zeng Y, Wu T, Lin D. Genome-wide association study identifes three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet 2011; 43: 679-684 [PMID: 21642993 DOI: 10.1038/ng.849]
57. Wang LD, Zhou FY, Li XM, Sun LD, Song X, Jin Y, Li JM, Kong GQ, Qi H, Cui J, Zhang LQ, Yang JZ, Li JL, Li XC, Ren JL, Liu ZC, Gao WJ, Yuan L, Wei W, Zhang YR, Wang WP, Sheyhidin I, Li F, Chen BP, Ren SW, Liu B, Li D, Ku JW, Fan ZM, Zhou SL, Guo ZG, Zhao XK, Liu N, Ai YH, Shen FF, Cui WY, Song S, Guo T, Huang J, Yuan C, Huang J, Wu Y, Yue WB, Feng CW, Li HL, Wang Y, Tian JY, Lu Y, Yuan Y, Zhu WL, Liu M, Fu WJ, Yang X, Wang HJ, Han SL, Chen J, Han M, Wang HY, Zhang P, Li XM, Dong JC, Xing GL, Wang R, Guo M, Chang ZW, Liu HL, Guo L, Yuan ZQ, Liu H, Lu Q, Yang LQ, Zhu FG, Yang XF, Feng XS, Wang Z, Li Y, Gao SG, Qige Q, Bai LT, Yang WJ, Lei GY, Shen ZY, Chen LQ, Li EM, Xu LY, Wu ZY, Cao WK, Wang JP, Bao ZQ, Chen JL, Ding GC, Zhuang X, Zhou YF, Zheng HF, Zhang Z, Zuo XB, Dong ZM, Fan DM, He X, Wang J, Zhou Q, Zhang QX, Jiao XY, Lian SY, Ji AF, Lu XM, Wang JS, Chang FB, Lu CD, Chen ZG, Miao JJ, Fan ZL, Lin RB, Liu TJ, Wei JC, Kong QP, Lan Y, Fan YJ, Gao FS, Wang TY, Xie D, Chen SQ, Yang WC, Hong JY, Wang L, Qiu SL, Cai ZM, Zhang XJ. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifes susceptibility loci at PLCE1 and C20orf54. Nat Genet 2010; 42: 759-763 [PMID: 20729853 DOI: 10.1038/ng.648]
58. Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO, Yuan JM, Zheng W, Dawsey SM, Dong LM, Lee MP, Ding T, Qiao YL, Gao YT, Koh WP, Xiang YB, Tang ZZ, Fan JH, Wang C, Wheeler W, Gail MH, Yeager M, Yuenger J, Hutchinson A, Jacobs KB, Giffen CA, Burdett L, Fraumeni JF, Tucker MA, Chow WH, Goldstein AM, Chanock SJ, Taylor PR. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 2010; 42: 764-767 [PMID: 20729852 DOI: 10.1038/ng.649]
59. Sameer AS, Parray FQ, Dar MA, Nissar S, Banday MZ, Rasool S, Gulzar GM, Chowdri NA, Siddiqi MA. Cyclin D1 G870A polymorphism and risk of colorectal cancer: a case control study. Mol Med Rep 2013; 7: 811-815 [PMID: 23354584 DOI: 10.3892/mmr.2013.1287]
60. Chen B, Cao L, Yang P, Zhou Y, Wu XT. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects. Cancer Epidemiol 2012; 36: 106-115 [PMID: 21606015 DOI: 10.1016/j.canep.2011.04.007]
61. Hong Y, Eu KW, Seow-Choen F, Fook-Chong S, Cheah PY. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore. Eur J Cancer 2005; 41: 1037-1044 [PMID: 15862753 DOI: 10.1016/j.ejca.2005.01.009]
62. Ceschi M, Sun CL, Van Den Berg D, Koh WP, Yu MC, Probst-Hensch N. The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modifed by oxidative stress among Chinese women in Singapore. Carcinogenesis 2005; 26: 1457-1464 [PMID: 15845652 DOI: 10.1093/carcin/ bgi093]
63. Grieu F, Malaney S, Ward R, Joseph D, Iacopetta B. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers. Anticancer Res 2003; 23: 4257-4259 [PMID: 14666635]
64. Zhuo W, Zhang L, Wang Y, Zhu B, Chen Z. Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians. Cancer Invest 2012; 30: 630-636 [PMID: 23020291 DOI: 10.3109/07357907.2012.726385]
65. Hussain S, M Y, Thakur N, Salam I, Singh N, Mir MM, Bhat MA, Siddiqi MA, Das BC, Bharadwaj M. Association of cy-clin D1 gene polymorphisms with risk of esophageal squa-mous cell carcinoma in Kashmir Valley: a high risk area. Mol Carcinog 2011; 50: 487-498 [PMID: 21268129 DOI: 10.1002/ mc.20732]
66. Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC, Mittal B. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esoph-ageal cancer. Cancer Detect Prev 2007; 31: 225-232 [PMID: 17561354 DOI: 10.1016/j.cdp.2007.04.005]
67. Casson AG, Zheng Z, Evans SC, Geldenhuys L, van Zanten SV, Veugelers PJ, Porter GA, Guernsey DL. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma. Cancer 2005; 104: 730-739 [PMID: 15971196 DOI: 10.1002/ cncr.21229]
68. Zhang J, Li Y, Wang R, Wen D, Sarbia M, Kuang G, Wu M, Wei L, He M, Zhang L, Wang S. Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. Int J Cancer 2003; 105: 281-284 [PMID: 12673692 DOI: 10.1002/ijc.11067]
69. Yu C, Lu W, Tan W, Xing D, Liang G, Miao X, Lin D. Lack of association between CCND1 G870A polymorphism and risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2003; 12: 176 [PMID: 12582032]
70. Liu G, Cescon DW, Zhai R, Zhou W, Kulke MH, Ma C, Xu W, Su L, Asomaning K, Heist RS, Wain JC, Lynch TJ, Christiani DC. p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esopha-geal adenocarcinoma. Dis Esophagus 2010; 23: 36-39 [PMID: 19302219 DOI: 10.1111/j.1442-2050.2009.00960.x]
71. van der Heiden IP, van der Werf M, Lindemans J, van Schaik RH. Sequencing: not always the "gold standard". Clin Chem 2004; 50: 248-249 [PMID: 14709666 DOI: 10.1373/ clinchem.2003.024604]
72. Heath EI, Limburg PJ, Hawk ET, Forastiere AA. Adenocar-cinoma of the esophagus: risk factors and prevention. Oncology (Williston Park) 2000; 14: 507-514; discussion 518-520, 522-523 [PMID: 10826312]
73. Chainani-Wu N. Diet and oral, pharyngeal, and esophageal cancer. Nutr Cancer 2002; 44: 104-126 [PMID: 12734057 DOI: 10.1207/S15327914NC4402_01]
74. Inadomi JM, Somsouk M, Madanick RD, Thomas JP, Shaheen NJ. A cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology 2009; 136: 2101-2114.e1-e6 [PMID: 19272389 DOI: 10.1053/j.gastro.2009.02.062]
75. Beaumont H, Gondrie JJ, McMahon BP, Pouw RE, Gregersen H, Bergman JJ, Boeckxstaens GE. Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility. Endoscopy 2009; 41: 2-8 [PMID: 19160152 DOI: 10.1055/s-0028-1103451]
76. Pouw RE, Gondrie JJ, Curvers WL, Sondermeijer CM, Ten Kate FJ, Bergman JJ. Successful balloon-based radiofrequen-cy ablation of a widespread early squamous cell carcinoma and high-grade dysplasia of the esophagus: a case report. Gastrointest Endosc 2008; 68: 537-541 [PMID: 18760181 DOI: 10.1016/j.gie.2008.03.1086]
77. Pouw RE, Gondrie JJ, Sondermeijer CM, Ten Kate FJ, van Gulik TM, Krishnadath KK, Fockens P, Weusten BL, Bergman JJ. Eradication of Barrett esophagus with early neopla-sia by radiofrequency ablation, with or without endoscopic resection. J Gastrointest Surg 2008; 12: 1627-1636; discussion 1627-1636 [PMID: 18704598 DOI: 10.1007/s11605-008-0629-1]
78. Lambert R. Endoscopy in screening for digestive cancer. World J Gastrointest Endosc 2012; 4: 518-525 [PMID: 23293721 DOI: 10.4253/wjge.v4.i12.518]
79. Blot WJ, Fraumeni JF. Time-related factors in cancer epidemiology. J Chronic Dis 1987; 40 Suppl 2: 1S-8S [PMID: 3312271]
80. Xing EP, Yang GY, Wang LD, Shi ST, Yang CS. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer. Clin Cancer Res 1999; 5: 1231-1240 [PMID: 10353761]
81. von Brevern MC, Hollstein MC, Cawley HM, De Benedetti VM, Bennett WP, Liang L, He AG, Zhu SM, Tursz T, Janin N, Trivers GE. Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors. Cancer Res 1996; 56: 4917-4921 [PMID: 8895744]
82. Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA. p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res 1991; 51: 4495-4499 [PMID: 1868473]
83. Cross AJ, Freedman ND, Ren J, Ward MH, Hollenbeck AR, Schatzkin A, Sinha R, Abnet CC. Meat consumption and risk of esophageal and gastric cancer in a large prospective study. Am J Gastroenterol 2011; 106: 432-442 [PMID: 20978481 DOI: 10.1038/ajg.2010.415]
84. Cross AJ, Leitzmann MF, Gail MH, Hollenbeck AR, Schatz-kin A, Sinha R. A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med 2007; 4: e325 [PMID: 18076279 DOI: 10.1371/journal.pmed.0040325]
85. Ward MH, Cross AJ, Abnet CC, Sinha R, Markin RS, Weisen-burger DD. Heme iron from meat and risk of adenocarcinoma of the esophagus and stomach. Eur J Cancer Prev 2012; 21: 134-138 [PMID: 22044848 DOI: 10.1097/CEJ.0b013e32834c9b6c]
86. Ward MH, Sinha R, Heineman EF, Rothman N, Markin R, Weisenburger DD, Correa P, Zahm SH. Risk of adenocar-cinoma of the stomach and esophagus with meat cooking method and doneness preference. Int J Cancer 1997; 71: 14-19 [PMID: 9096659]
87. Kawaguchi H, Ohno S, Araki K, Miyazaki M, Saeki H, Watanabe M, Tanaka S, Sugimachi K. p53 polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res 2000; 60: 2753-2755 [PMID: 10850407]